Sign in

CIK 0001850119 · <br>Emerging growth company

Century Therapeutics, Inc.

Sign in to watch
Ticker
IPSC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
842040295
Phone
215-981-4000
Business address
25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
  1. 4 Grant or award SVP Finance & Operations acquired 110,000 shares (grant or award)
  2. 4 Shares withheld for taxes Chief Scientific Officer gave up 1,611 shares (to pay taxes)
  3. 4 Open-market buy Chief Scientific Officer bought 58,060 shares at $0.85 ($49,252)
  4. 4 Open-market buy President and CEO bought 52,000 shares at $0.58 ($30,352)
  5. 4 Shares withheld for taxes President and CEO gave up 463 shares (to pay taxes)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale SVP Finance & Operations sold 257 shares at $0.53 ($137)
  9. 4 Open-market sale See Remarks sold 526 shares at $0.53 ($280)
  10. 4 Open-market sale Chief Scientific Officer sold 5,462 shares at $0.50 ($2,736)
  11. 4 Open-market buy President and CEO bought 35,000 shares at $0.50 ($17,329)
  12. 4 Open-market sale President and CEO sold 32,456 shares at $0.45 ($14,735)
  13. 4 Open-market sale SVP Finance & Operations sold 292 shares at $0.59 ($171)
  14. 4 Grant or award Chief Scientific Officer acquired 762,543 shares (grant or award)
  15. 4 Open-market sale SVP Finance & Operations sold 263 shares at $0.50 ($132)
  16. 4 Open-market sale President and CEO sold 488 shares at $0.50 ($244)
  17. 4 Open-market sale See Remarks sold 539 shares at $0.50 ($270)
  18. 4 Grant or award President and CEO acquired 1,587,614 shares (grant or award)
  19. 4 Open-market sale SVP Finance & Operations sold 296 shares at $0.53 ($158)
  20. 4 Derivatives Options or other derivatives

Page 3 of 10 · 188 filings